Chronic hemodialysis patients with COVID-19 cared for by the public health system have higher mortality than those treated in private facilities: analysis of the Brazilian dialysis registry
- PMID: 35994131
- PMCID: PMC9395793
- DOI: 10.1007/s11255-022-03289-z
Chronic hemodialysis patients with COVID-19 cared for by the public health system have higher mortality than those treated in private facilities: analysis of the Brazilian dialysis registry
Abstract
Purpose: Brazil is the third country globally in dialysis patients. Little is known about the impact of the type of health insurance on the outcome of these patients after COVID-19.
Methods: We analyzed comorbidities, sociodemographic factors, and dialysis-related parameters from a retrospective cohort study of 1866 Brazilian chronic hemodialysis patients with COVID-19 from Feb 2020-July 2021. We evaluated the influence of health insurance (private vs. public) on the intensive care unit admission and 90 day fatality risk.
Results: From 1866 hemodialysis patients, 455 (24%) were admitted to the intensive care unit, and 350 (19%) died. The mean age was 57.5 years, 88% had public health insurance. Crude case-fatality rate was not different between groups (private vs. public risk ratio 1.11; 95% CI 0.82-1.52, p = 0.498). In fully adjusted multivariate models, patients with private health insurance did not have a higher chance to be admitted to an intensive care unit (odds ratio 0.97; 95% CI 0.63-1.50, p = 0.888), but they presented a lower death risk (hazard ratio 0.56; 95% CI 0.37-0.85, p = 0.006).
Conclusion: The type of health insurance did not influence the access of hemodialysis patients with COVID-19 to an intensive care unit, but patients with private health insurance had a lower mortality risk.
Keywords: COVID-19; Healthcare disparities; Hemodialysis; Intensive care unit; Mortality.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
The authors have no conflicts of interest in relation to the study performed.
Figures
References
-
- Brazil (2021) Painel coronavírus. https://covid.saude.gov.br/. Accessed 24 Aug 2021
-
- de Souza WM, Buss LF, Candido DDS, Carrera JP, Li S, Zarebski AE, Pereira RHM, Prete CA, Jr, de Souza-Santos AA, Parag KV, Belotti M, Vincenti-Gonzalez MF, Messina J, da Silva Sales FC, Andrade PDS, Nascimento VH, Ghilardi F, Abade L, Gutierrez B, Kraemer MUG, Braga CKV, Aguiar RS, Alexander N, Mayaud P, Brady OJ, Marcilio I, Gouveia N, Li G, Tami A, de Oliveira SB, Porto VBG, Ganem F, de Almeida WAF, Fantinato F, Macario EM, de Oliveira WK, Nogueira ML, Pybus OG, Wu CH, Croda J, Sabino EC, Faria NR. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nat Hum Behav. 2020;4(8):856–865. doi: 10.1038/s41562-020-0928-4. - DOI - PubMed
-
- Prichard SS. Comorbidities and their impact on outcome in patients withend-stage renal disease. Kidney Int. 2000;57:S100–S104. doi: 10.1046/j.1523-1755.2000.07417.x. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
